AgingResearch.News
Frontiers in Pharmacology

Tirzepatide for obesity without diabetes: mechanistic insights, clinical evidence, and future directions

By Wenting He, SONG Yi-di, Xinyu Wang, Show 4 more authorsEn-Wu Long
Figure 1. Mechanisms of weight loss in dual GIP and GLP-1 receptor agonists.
Open the figure at full size
Figure 1. Mechanisms of weight loss in dual GIP and GLP-1 receptor agonists.Mechanisms of weight loss in dual GIP and GLP-1 receptor agonists.He et al.
ReviewInterventions
Paper

The paper

Wenting He, SONG Yi-di, Xinyu Wang, Show 4 more authorsEn-Wu Long

University of Electronic Science and Technology of China

Frontiers in Pharmacology, 18 Aug 2026

doi.org/10.3389/fphar.2026.1889594PubMed 42683151

More on GLP-1 and incretin signalling